Evidence map›Paper›PMID 28494075›Full record

ArticleJAMA ophthalmology2017

Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study.

Andrew Bastawrous, Wanjiku Mathenge, Tunde Peto, Nisha Shah, Kevin Wing, Hillary Rono, Helen A Weiss, David Macleod, Allen Foster, Matthew Burton and 1 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in JAMA ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (Study of Health in Pomerania-TREND-1).Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Andrew BastawrousInternational Centre for Eye Health, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, England.
Wanjiku MathengeRwanda International Institute of Ophthalmology and Dr Agarwal's Eye Hospital, Kigali, Rwanda.
Tunde PetoDepartment of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, England4Centre for Public Health, Queen's University Belfast, United Kingdom.
Nisha ShahNational Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust, London, England6University College London Institute of Ophthalmology, London, England.
Kevin WingDepartment of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, England.
Hillary RonoInternational Centre for Eye Health, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, England7Kitale Eye Unit, Kitale, Kenya.
Helen A WeissMedical Research Council Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, England.
David MacleodMedical Research Council Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, England.
Allen FosterInternational Centre for Eye Health, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, England.
Matthew BurtonInternational Centre for Eye Health, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, England9Moorfields Eye Hospital National Health Service Foundation Trust, London, England.
Hannah KuperInternational Centre for Eye Health, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, England.
London School of Hygiene & Tropical Medicine · GBMedical Research Council · GBNational Health Service · GBQueen's University Belfast · GBUniversity College London · GB

Funding

Medical Research Council G0700837Medical Research Council G1001934Wellcome Trust 098481/Z/12/Z
6 · The paper itself

Abstract

Importance: The incidence of age-related macular degeneration (AMD) is unknown in Africa. Objective: To estimate the 6-year cumulative incidence and progression of AMD in older adults (≥50 years old) in Nakuru, Kenya. Design, Setting, and Participants: This study assessed a population-based cohort with 6-year follow-up of 4414 participants who had a complete assessment. Random cluster sampling with probability proportionate to size procedures was used to select a representative, cross-sectional sample of adults 50 years and older from January 26, 2007, through November 11, 2008. A 6-year follow-up was undertaken from January 7, 2013, through March 12, 2014. On both occasions, a comprehensive ophthalmic examination was performed that included logMAR visual acuity, digital retinal photography, and grading of images at Moorfields Eye Hospital Reading Centre. Data were collected on general health and risk factors. Main Outcomes and Measures: Incident AMD in participants with no AMD at baseline and progression from early to late AMD. Results: A total of 1453 of the 2900 individuals (50.1%) at risk for AMD were followed up after 6 years (mean [SD] age, 60.7 [8.2] years; 635 female [49.5%]; 799 Kikuyu [62.3%], 324 Kalenjin [25.3%], and 159 other [12.4%]); 1282 had data on AMD status at follow-up. Of these, 202 developed early AMD, and no participants developed late AMD. The 6-year weighted (for loss to follow-up) cumulative incidence of early AMD was 164.2 per 1000 persons (95% CI, 136.7-195.9 per 1000 persons). Two individuals with baseline early AMD from the 142 at risk had developed late AMD at follow-up, with a 6-year cumulative incidence of progression from early to late AMD of 24.5 per 1000 persons (95% CI, 5.0-111.7 per 1000 persons). Cumulative incidence of AMD increased with age (≥80 years old vs 50-59 years old: 1.8; 95% CI, 0.9-3.5) and was higher in women (female vs male: 1.6; 95% CI, 1.2-2.1) and persons with diabetes (diabetes vs no diabetes: 1.7; 95% CI, 1.0-2.8). Conclusions and Relevance: In Kenya, more than 100 000 estimated new cases of AMD, mainly early AMD, will develop every year in individuals 50 years or older, although a 50% loss to follow-up and wide CIs for progression to late AMD limit definitive conclusions from these findings.

Indexed as

Population SurveillanceVisual AcuityAdultAgedAged, 80 and overAge DistributionCross-Sectional StudiesDisease ProgressionFemaleFollow-Up StudiesHumansIncidenceKenyaMacular DegenerationMaleMiddle Aged

Identifiers

PMID28494075
PMCPMC5710264
OpenAlexW2612357299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.